key: cord-0932119-6wmopixn
authors: Vassallo, Ralph R.; Kamel, Hany; Dumont, Larry J.; Bravo, Marjorie D.
title: The evolution of COVID‐19 vaccination within a US blood center
date: 2021-06-30
journal: Transfusion
DOI: 10.1111/trf.16579
sha: 6ee87d87744574904cbee337bafe01018e0c25ee
doc_id: 932119
cord_uid: 6wmopixn

nan

A national blood center licensed predominantly in the western half of the United States questions blood donors regarding receipt of at least 1 dose of COVID-19 vaccine and tests blood samples for the presence of SARS-CoV-2 antibodies (total Ig anti-spike, VITROS Anti-SARS-CoV-2 Total Reagent Pack, Ortho Clinical Diagnostics, Rochester, NY). All positive anti-spike samples are reflexed to a total Ig nucleocapsid (NC) antibody assay (Elecsys Anti-SARS-CoV-2, Roche Diagnostics, Indianapolis, IN). Successful allogeneic blood donors (n =~428,925; convalescent plasma donors excluded) had a higher proportion of self-reported vaccinations than Ameri-cans aged ≥16 years as per the Centers for Disease Control and Prevention, although the trajectory and geographic variability of the observed increase from 5% to 71.7% over 19 weeks was similar. 1,2 Figure 1 shows by-donor data within each week. Returning donors were recounted in different weekly cohorts. As repeat donations grew from individuals previously reporting vaccination (without a documented interval prior to donation), the rate of spike antibody positivity rose from 55% to 98.5%. Of vaccinees with spike antibodies, 13%-20% also demonstrated NC antibody, suggestive of illness-related exposure to NC antigen in addition to spike exposure through vaccination and/or COVID-19 infection. Of individuals denying vaccination, spike antibody proportions increased from 14% to as high as 38% with associated NC antibody positivity of 93%-95%, indicating a true rise in natural COVID-19 infection for this group. This is consistent with latest available values suggesting that 9.1% of donations with spike antibodies are from unvaccinated individuals (compared with 9.9% predicted from self-reported non-vaccinees with NC antibody-confirmed spike antibody).

Demographic trends of people receiving COVID-19 vaccinations in the United States

The evolution of COVID-19 vaccination within a US blood center

ACKNOWLEDGEMENTS Partial funding was provided through National Heart, Lung, and Blood Institute contracts HHSN 75N92019D00032 and HHSN 75N92019D00033 and the Centers for Disease Control and Prevention contract 75D30120C08170.

ORCID Ralph R. Vassallo https://orcid.org/0000-0001-8754-047X Larry J. Dumont https://orcid.org/0000-0002-1715-0748